Younis Nancy S, Mohamed Maged E
Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Zagazig University Hospitals, Zagazig University, Zagazig 44519, Egypt.
Pharmaceuticals (Basel). 2023 Mar 15;16(3):442. doi: 10.3390/ph16030442.
Anethole (AN) is one of the major constituents of several plant oils, demonstrating plentiful pharmacological actions. Ischemic stroke is the main cause of morbidity and death worldwide, particularly since ischemic stroke therapeutic choices are inadequate and limited; thus, the development of new therapeutic options is indispensable. This study was planned to explore the preventive actions of AN in ameliorating cerebral ischemia/reperfusion-induced brain damage and BBB permeability leakage, as well as to explore anethole's potential mechanisms of action. The proposed mechanisms included modulating JNK and p38 as well as MMP-2 and MMP-9 pathways. Sprague-Dawley male rats were randomly assigned into four groups: sham, middle cerebral artery occlusion (MCAO), AN125 + MCAO, and AN250 + MCAO. Animals in the third and fourth groups were pretreated with AN 125 or 250 mg/kg orally, respectively, for two weeks before performing middle cerebral artery occlusion (MCAO)-induced cerebral ischemic/reperfusion surgery. Animals that experienced cerebral ischemia/reperfusion exhibited amplified infarct volume, Evans blue intensity, brain water content, Fluoro-Jade B-positive cells, severe neurological deficits, and numerous histopathological alterations. MCAO animals exhibited elevated MMP-9 and MMP-2 gene expressions, enzyme activities, augmented JNK, and p38 phosphorylation. On the other hand, pretreatment with AN diminished the infarct volume, Evans blue dye intensity, brain water content, and Fluoro-Jade B-positive cells, improved the neurological score and enhanced histopathological examination. AN effectively lowered MMP-9 and MMP-2 gene expression and enzyme activities and diminished phosphorylated JNK, p38. AN decreased MDA content, amplified GSH/GSSG ratio, SOD, and CAT, decreased the serum and brain tissue homogenate inflammatory cytokines (TNF-α, IL-6, IL-1β), NF-κB, and deterred the apoptotic status. This study revealed the neuroprotective ability of AN against cerebral ischemia/reperfusion in rats. AN boosted blood-brain barrier integrity via modulating MMPs and diminished oxidative stress, inflammation, and apoptosis through the JNK/p38 pathway.
茴香脑(AN)是几种植物油的主要成分之一,具有多种药理作用。缺血性中风是全球发病和死亡的主要原因,特别是由于缺血性中风的治疗选择不足且有限;因此,开发新的治疗方法必不可少。本研究旨在探讨AN在改善脑缺血/再灌注诱导的脑损伤和血脑屏障通透性渗漏方面的预防作用,并探讨茴香脑的潜在作用机制。提出的机制包括调节JNK和p38以及MMP-2和MMP-9途径。将Sprague-Dawley雄性大鼠随机分为四组:假手术组、大脑中动脉闭塞(MCAO)组、AN125+MCAO组和AN250+MCAO组。第三组和第四组动物在进行大脑中动脉闭塞(MCAO)诱导的脑缺血/再灌注手术前两周,分别口服125或250mg/kg的AN进行预处理。经历脑缺血/再灌注的动物表现出梗死体积增大、伊文思蓝强度增加、脑含水量增加、氟玉红B阳性细胞增多、严重神经功能缺损以及许多组织病理学改变。MCAO动物表现出MMP-9和MMP-2基因表达升高、酶活性增强、JNK和p38磷酸化增加。另一方面,AN预处理可减少梗死体积、伊文思蓝染料强度、脑含水量和氟玉红B阳性细胞,改善神经评分并增强组织病理学检查。AN有效降低MMP-9和MMP-2基因表达及酶活性,并减少磷酸化JNK、p38。AN降低MDA含量,提高GSH/GSSG比值、SOD和CAT,降低血清和脑组织匀浆中的炎性细胞因子(TNF-α、IL-6、IL-1β)、NF-κB,并阻止细胞凋亡状态。本研究揭示了AN对大鼠脑缺血/再灌注的神经保护能力。AN通过调节MMPs增强血脑屏障完整性,并通过JNK/p38途径减少氧化应激、炎症和细胞凋亡。